Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Centre Hospitalier Universitaire Dijon
Age
18–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Participants with a history of asymptomatic/mildly symptomatic SARS-CoV2 infection:
Age ≥18 years
Participant who has provided consent
Participant affiliated to National health insurance
Participant with asymptomatic or minimally symptomatic SARS CoV2 infection who did not require hospitalization at least 6 months prior to study inclusion.
SARS CoV2 infection proven by positive PCR or antigenic test at the time of signs of infection or positive SARS-CoV2 infection-specific serology at the time of infection (IgG+).
Participants with a history of symptomatic SARS-CoV2 infection hospitalized at the Dijon University Hospital excluding the intensive care unit:
Age ≥18 years
Participant having provided consent
Participant affiliated to National health insurance
Participant having presented a symptomatic SARS CoV2 infection requiring admission to a regular hospital unit at least 6 months prior to inclusion in the study.
SARS CoV2 infection proven by a positive PCR or antigenic test at the time of signs of infection or a positive SARS-CoV2 specific serology at the time of infection (IgG+).
Participants with a history of symptomatic SARS-CoV2 infection hospitalized at Dijon University Hospital in the ICU:
Age ≥18 years
Participant who has provided consent
Participant affiliated to National health insurance
Participant with symptomatic SARS CoV2 infection requiring admission to an intensive care unit at least 6 months prior to study inclusion.
SARS CoV2 infection proven by a positive PCR or antigenic test at the time of signs of infection or a positive SARS-CoV2 specific serology at the time of infection (IgG+).
Participants with no history of SARS-CoV2 infection:
Age≥18 years
Participant who has provided consent
Participant affiliated to National health insurance
Participant with no evidence of SARS CoV2 infection and negative SARS-CoV2 serology.
For vaccinated participants: negative specific serology for SARS-CoV2 infection
You may not be if
For all participants:
SARS Cov2 vaccination within one month prior to inclusion.
Previous SARS Cov1 infection documented
Previous study participant
Participant under legal protection (guardianship)
Participant subject to a legal protection measure
A protected adult
Pregnant, parturient or breastfeeding women
Treatment with corticosteroids in the last year
Treatment with lipid-lowering drugs
Known genetic mutation modifying HDL cholesterol
Progressive neoplasia
Chronic alcoholism
Primary biliary cirrhosis
Hyperthyroidism
Unstable hypothyroidism
History of cardiac or cardiovascular side effects following SARS-CoV2 vaccination (thrombosis, myocarditis etc)
For participants with a history of asymptomatic/mildly symptomatic SARS-CoV2 infection:
\- Hospitalization with a prior SARS-CoV2 infection in a conventional or intensive care unit
For participants with a history of symptomatic SARS-CoV2 infection hospitalized outside the ICU:
\- Previous ICU hospitalization for SARS-CoV2 infection
For participants with no history of SARS-CoV2 infection:
Previous positive SARS-CoV2 PCR
Negative SARS-CoV2 PCR and presence of clinical symptoms suggestive of SARS-CoV2 infection
Previous positive serology for SARS-CoV2 infection
For healthy volunteers with no history of SARS-CoV2 infection:
Positive specific serology for SARS-CoV2 infection at the screening visit.
Clareo Health | Qualitative and Functional Investigation of Lipids in Patients With SARS-CoV2 Infection - In Search of Atherogenic Sequelae
